OQS
GH icon

Occudo Quantitative Strategies’s Guardant Health GH Stock Holding History

Occudo Quantitative Strategies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
82,847
+62,481
+307% +$6.8M 0.66% 27
2026
Q1 		$1.77M Buy
20,366
+3,878
+24% +$389K 0.1% 286
2025
Q4 		$1.68M Buy
16,488
+12,506
+314% +$1.12M 0.11% 231
2025
Q3 		$249K Sell
3,982
-5,166
-56% -$281K 0.03% 534
2025
Q2 		$476K Buy
+9,148
New +$409K 0.05% 358

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Occudo Quantitative Strategies's GH Position: Q2 2026 in Review

Occudo Quantitative Strategies increased its Guardant Health (GH) stake by 307% in Q2 2026, buying an estimated $6.8M and bringing the position to 82,847 shares worth $12.4M. The position accounts for 0.66% of the portfolio, ranked #27.

Occudo Quantitative Strategies first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Occudo Quantitative Strategies held 82,847 shares of Guardant Health worth $12.4M as of Q2 2026.
  • Occudo Quantitative Strategies bought 62,481 Guardant Health shares in Q2 2026, an estimated $6.8M.
  • Guardant Health made up 0.66% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #27 holding.
  • Occudo Quantitative Strategies first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.